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Background: Morphological characteristics of in-stent restenosis (ISR) by optical coherence tomography (OCT) have not been clarified yet. We 
therefore evaluated the various ISR pattern by OCT.
Methods: Patients (n=86, 88 lesions) presenting with angiographycally documented ISR from June 2008 to August 2009 were included. Qualitative 
restenotic tissue analysis by OCT included the assessment of tissue structure (homogeneous, heterogeneous, or layered), predominant backscatter 
(high or low), visible microvessels, lumen shape, and the presence of intraluminal material. The types and numbers of stent were as follows: 
sirolimus-eluting stent in 63 (71.8%), paclitaxel-eluting stent in 14 (15.9%), bare-metal stent in 10 (1.4%), and biolimus-eluting stent in 1 (1.1%) of 
the 88 lesions. Restenosis pattern was angiographycally classified by lesion length as diffuse (>10mm) and focal (<10mm). Restenosis timing was 
classified by the length of time after stent implantation as midterm (<1 year) and late (>1 year).
Results: Diffuse restenosis was found in 14 (15.9%) lesions. The tissue structure was homogenous in 45 (51.1%), layered in 35 (39.8%), and 
heterogeneous in 8 (9.1%) lesions. The predominant backscatter was high in 52 (59.1%) lesions. The lumen shape was irregular in 32 (36.4%) 
lesions. The presence of intraluminal material was observed in 36 (40.1%) lesions. Microvessels were visible in 11 (12.5%) lesions. Paclitaxel-eluting 
stent had significantly higher frequency than sirolimus-eluting stent in heterogeneous tissue (35.7% vs 4.8%, p=0.0031) and low backscatter (71.4% 
vs 34.9%, p=0.027). The tissue structure was more homogeneous than layered (64.3% vs 39.1%, p=0.032) in midterm restenosis, however, more 
layered than homogeneous in late restenosis (54.3% vs 23.8%, p=0.0068).
Conclusions: Our study suggested that the mechanism of stent restenosis may differ depending on stent type and the restenosis process may 
change between midterm and late restenoses.
